Fundz

Schrödinger, Inc. received a $10M grant from the Bill & Melinda Gates Foundation to expand its computational tools for predictive toxicology in drug discovery.

PUBLIC · SDGRJul 29, 2024

Amount Raised

$10 Million

Round Type

Grant

New YorkBiotechnology

Investors

Bill & Melinda Gates Foundation

Description

Schrödinger, Inc. announced an initiative aimed at enhancing its computational platform to predict toxicology risk early in drug discovery, funded by a $10 million grant from the Bill & Melinda Gates Foundation. The project will aid in developing new drugs particularly for low- and middle-income countries.

Quick answer

Schrodinger, Inc. raised $10 Million in a Grant round, dated July 29, 2024. Investors: Bill & Melinda Gates Foundation. Schrodinger, Inc. is based in New York, New York, United States.

How much did Schrodinger, Inc. raise?
Schrodinger, Inc. raised $10 Million in a Grant round on July 29, 2024.
Who invested in Schrodinger, Inc?
Bill & Melinda Gates Foundation is named as investors in this round.
What does Schrodinger, Inc. do?
Schrödinger is involved in computational drug designing for pharmaceutical and biotechnology research.
Where is Schrodinger, Inc. based and how big is it?
Schrodinger, Inc. is based in New York, New York, United States. Fundz records about 900 employees.
Who are the decision-makers at Schrodinger, Inc?
Fundz holds 1 contact at Schrodinger, Inc., including the Vice President of Global Strategic Accounts. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Schrodinger, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Oruka Therapeutics raised $200M (Post-IPO Equity) on September 12, 2024.
  • Sinopia Biosciences raised $2.2M (Seed) on September 12, 2024.
  • Novameat raised $19M (Series A) on September 12, 2024.
  • Wundrsight raised $400K (Seed) on September 12, 2024.
  • XS Innovations raised $1.2M (Seed) on September 12, 2024.
  • Inflammatix raised $57M (Series E) on September 12, 2024.

Who to call at Schrodinger, Inc., and when

A new round usually means Schrodinger, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Schrodinger, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Schrodinger, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Schrodinger, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Schrodinger, Inc.

Location

New York, New York, United States

About

Schrödinger is involved in computational drug designing for pharmaceutical and biotechnology research.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Schrodinger, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsMagdalene R., Vice President of Global Strategic Acco…See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Schrodinger, Inc.'s next move

See what Strategic adds

Schrodinger, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.